Skip to content
WealthTicker

Low-drawdown equity screen: why 29 of 31 funds are young

31 equity funds beat 12% a year over 3 years without ever falling 20%. 29 began after the 2020 crash; of 279 older funds, only 3 never fell 20%.

·

A metallic shield in front of neatly stacked documents

What the screen asks for

The low-drawdown equity screen sits in the screener's Risk-adjusted returns group. Its rule:

  • the fund is an equity fund,
  • its maximum drawdown is shallower than 20%, and
  • its three-year CAGR is above 12%.

The page adds its own housekeeping: Direct plans only, Growth option, no segregated portfolios or schemes that have stopped publishing a NAV. It ranks the funds that pass by three-year CAGR. There is no size floor.

The pairing makes sense. A return figure says what you ended with; a drawdown says what the worst stretch felt like on the way, which is often the moment people sell. A fund that delivered 12% or more without a 20% fall would have been easier to hold.

One detail decides almost everything about the result: the drawdown is measured over the fund's whole history, from its first NAV to 9 October 2026, not over a fixed window.

How many pass

Of 418 Direct equity funds with a three-year record, 210 beat 12% a year. Only 31 of those also never fell 20%. The ten with the highest three-year CAGR, as of NAVs to 9 October 2026:

Fund Type 3Y CAGR Worst fall First NAV AUM (₹ Cr)
HDFC Pharma and Healthcare Healthcare 29.29% -14.91% Oct 2023 3,128
Mirae Asset Healthcare Healthcare 21.95% -19.98% Jul 2018 3,458
LIC MF Healthcare Healthcare 20.87% -15.10% Jul 2023 99
WhiteOak Capital Mid Cap Mid cap 20.63% -19.33% Sep 2022 7,096
ITI Pharma and Healthcare Healthcare 18.73% -17.69% Nov 2021 266
Axis Multicap Multi cap 18.47% -18.08% Dec 2021 11,430
ICICI Prudential Innovation Thematic 18.07% -16.51% May 2023 7,836
Tata India Pharma & Healthcare Healthcare 17.89% -19.84% Dec 2015 1,534
WhiteOak Capital Multi Cap Multi cap 17.65% -16.93% Sep 2023 4,222
LIC MF Multi Cap Multi cap 17.11% -19.32% Nov 2022 2,173

AUM is each scheme's average for July to September 2026, all plans together.

What fills the list

Healthcare funds. Five of the 31, including both funds older than 2020. Neither fell 20% in March 2020, when the Nifty 50 index fund fell 38.42%: Mirae Asset Healthcare's worst fall came then, at 19.98%, just inside the line.

Multi cap and flexi cap funds: seven multi cap and five flexi cap. The other 14 are three ELSS, two value, two mid cap, one focused, one large cap and five more thematic funds (three business cycle, one innovation, one financial services).

One fund house more than any other. WhiteOak Capital has five of the 31: its mid cap, multi cap, flexi cap, ELSS and large cap funds, all launched in 2022 or 2023.

Small funds. With no AUM floor, LIC MF Healthcare at ₹99 crore sits beside ICICI Prudential Flexi Cap, the largest in the list at ₹24,586 crore (14.96% over three years, worst fall 19.71%).

Why the list is so young

29 of the 31 funds published their first NAV after the March 2020 crash. The oldest of those, DSP Value Fund, began in December 2020; 25 of the 31 have no five-year record at all.

That is the full-history drawdown at work. The UTI Nifty 50 Index Fund fell 38.42% at its worst, in March 2020; its worst fall in the last three years was 15.51%. Among the 279 Direct equity funds with NAVs from before 2020, the median worst-ever fall is 36.94%, and only 3 of the 279 have never fallen 20%. An older fund cannot pass this screen unless it dodged 2020, as the pharma funds did.

The younger funds' worst moments came later and were shallower. For 26 of the 31, the deepest fall bottomed between February and April 2025.

If every fund were judged on its worst fall in the last three years instead, 97 would pass rather than 31. Our post on the worst fall in three years by category uses that common window.

What it leaves out

  • Nearly every fund that lived through 2020, however well it has done since.
  • Small-cap funds. None pass; their falls have been deeper.
  • Funds under three years old, which have no three-year CAGR to test.
  • Hybrid funds, which are not in the equity category even when they hold mostly shares.

How to read it

A shallow drawdown in a short life is not proof of a shallow fund. A fund launched in 2023 has not met a fall like 2020's. Its -17% may be a good portfolio or a calm three years. The screen cannot tell which, and neither can we.

Compare like with like. Before reading much into the worst-fall column, check each fund's first NAV date on its page. Axis Multicap vs WhiteOak Capital Multi Cap puts two of the multi caps side by side; their records start almost two years apart.

Drawdown is one measure among several. Volatility, Sortino and capture ratios describe the ride differently; risk-adjusted returns explains how they fit together.

The list moves. The screen reruns on every day's NAVs. One sharp fall can push a fund past -20% for good, since a full-history drawdown never shrinks, and a fund turning three can join.

These are past figures computed from each fund's NAV history. A screen narrows a list; it does not rank funds by merit, and nothing here is a recommendation to buy or sell any of them.

Frequently asked questions

Which equity funds never fell more than 20% and still returned over 12% a year?

As of NAVs to 9 October 2026, 31 Direct equity funds had a worst-ever fall shallower than 20% and a three-year CAGR above 12%. HDFC Pharma and Healthcare led at 29.29% a year with a worst fall of 14.91%, followed by Mirae Asset Healthcare at 21.95%.

Why are most funds in the low-drawdown equity screen less than five years old?

The screen reads each fund's maximum drawdown over its whole history. Funds with NAVs before 2020 lived through the March 2020 crash, and the median one among 279 such funds fell 36.94% at its worst. 29 of the 31 funds that pass began after that crash.

How far did the Nifty 50 fall in March 2020 compared with recent years?

The UTI Nifty 50 Index Fund's worst fall since 2013 was 38.42%, in March 2020. Its worst fall in the last three years was 15.51%.

This is commentary on published data, not investment advice. WealthTicker is not a SEBI-registered adviser or distributor. Figures are WealthTicker’s own calculations from public data — AMFI’s fund NAVs and disclosures, NSE’s index and FII/DII files, and the fund houses’ monthly portfolios (how we calculate). They are as of the dates stated and can be revised by their source.